Molecular/clinical correlations in females with fragile X

William E. Sobesky, Annette K. Taylor, Bruce F. Pennington, Loisa Bennetto, Deborah Porter, Jeannette Riddle, Randi J Hagerman

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

Females who are affected by fragile X syndrome (FXS) can have significant physical, neuropsychological and emotional involvement. This study was designed to explore the relationships between these three domains and to learn how the degree of involvement in each of these phenotypic areas relates to molecular parameters including CGG repeat length and activation ratio (the proportion of normal FMR1 alleles on the active X chromosome). Three groups of females were studied: 35 women who grew up in a fragile X family but do not carry an FMR1 mutation, 92 women with a premutation, and 29 women with a full mutation. Correlations between neurocognitive, physical and emotional traits were calculated for each of the three groups. Within the full mutation group significant correlations were seen between schizotypal traits and full scale IQ. The Lie scale was significantly correlated with the physical findings index. The activation ratio correlated significantly with the measure of executive function (r = .50, P = .01). There was a trend toward correlations of activation ratio with the physical index score, outer ear prominence and IQ. CGG repeat number significantly correlated only with the physical index (r = .44, P = .01). Thus, activation ratio may be the more pertinent molecular parameter in full mutation women in determining the degree of cognitive and physical phenotypic involvement.

Original languageEnglish (US)
Pages (from-to)340-345
Number of pages6
JournalAmerican Journal of Medical Genetics
Volume64
Issue number2
DOIs
StatePublished - Aug 9 1996
Externally publishedYes

Fingerprint

Mutation
External Ear
Fragile X Syndrome
Executive Function
X Chromosome
Alleles

Keywords

  • CGG repeats
  • fragile X females
  • neurocognitive deficits
  • physical findings
  • schizotypy
  • X-inactivation ratio

ASJC Scopus subject areas

  • Genetics(clinical)
  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology

Cite this

Molecular/clinical correlations in females with fragile X. / Sobesky, William E.; Taylor, Annette K.; Pennington, Bruce F.; Bennetto, Loisa; Porter, Deborah; Riddle, Jeannette; Hagerman, Randi J.

In: American Journal of Medical Genetics, Vol. 64, No. 2, 09.08.1996, p. 340-345.

Research output: Contribution to journalArticle

Sobesky, William E. ; Taylor, Annette K. ; Pennington, Bruce F. ; Bennetto, Loisa ; Porter, Deborah ; Riddle, Jeannette ; Hagerman, Randi J. / Molecular/clinical correlations in females with fragile X. In: American Journal of Medical Genetics. 1996 ; Vol. 64, No. 2. pp. 340-345.
@article{d1254e64bc824a94b6d8ef53e8b64a83,
title = "Molecular/clinical correlations in females with fragile X",
abstract = "Females who are affected by fragile X syndrome (FXS) can have significant physical, neuropsychological and emotional involvement. This study was designed to explore the relationships between these three domains and to learn how the degree of involvement in each of these phenotypic areas relates to molecular parameters including CGG repeat length and activation ratio (the proportion of normal FMR1 alleles on the active X chromosome). Three groups of females were studied: 35 women who grew up in a fragile X family but do not carry an FMR1 mutation, 92 women with a premutation, and 29 women with a full mutation. Correlations between neurocognitive, physical and emotional traits were calculated for each of the three groups. Within the full mutation group significant correlations were seen between schizotypal traits and full scale IQ. The Lie scale was significantly correlated with the physical findings index. The activation ratio correlated significantly with the measure of executive function (r = .50, P = .01). There was a trend toward correlations of activation ratio with the physical index score, outer ear prominence and IQ. CGG repeat number significantly correlated only with the physical index (r = .44, P = .01). Thus, activation ratio may be the more pertinent molecular parameter in full mutation women in determining the degree of cognitive and physical phenotypic involvement.",
keywords = "CGG repeats, fragile X females, neurocognitive deficits, physical findings, schizotypy, X-inactivation ratio",
author = "Sobesky, {William E.} and Taylor, {Annette K.} and Pennington, {Bruce F.} and Loisa Bennetto and Deborah Porter and Jeannette Riddle and Hagerman, {Randi J}",
year = "1996",
month = "8",
day = "9",
doi = "10.1002/(SICI)1096-8628(19960809)64:2<340::AID-AJMG21>3.0.CO;2-E",
language = "English (US)",
volume = "64",
pages = "340--345",
journal = "American Journal of Medical Genetics",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Molecular/clinical correlations in females with fragile X

AU - Sobesky, William E.

AU - Taylor, Annette K.

AU - Pennington, Bruce F.

AU - Bennetto, Loisa

AU - Porter, Deborah

AU - Riddle, Jeannette

AU - Hagerman, Randi J

PY - 1996/8/9

Y1 - 1996/8/9

N2 - Females who are affected by fragile X syndrome (FXS) can have significant physical, neuropsychological and emotional involvement. This study was designed to explore the relationships between these three domains and to learn how the degree of involvement in each of these phenotypic areas relates to molecular parameters including CGG repeat length and activation ratio (the proportion of normal FMR1 alleles on the active X chromosome). Three groups of females were studied: 35 women who grew up in a fragile X family but do not carry an FMR1 mutation, 92 women with a premutation, and 29 women with a full mutation. Correlations between neurocognitive, physical and emotional traits were calculated for each of the three groups. Within the full mutation group significant correlations were seen between schizotypal traits and full scale IQ. The Lie scale was significantly correlated with the physical findings index. The activation ratio correlated significantly with the measure of executive function (r = .50, P = .01). There was a trend toward correlations of activation ratio with the physical index score, outer ear prominence and IQ. CGG repeat number significantly correlated only with the physical index (r = .44, P = .01). Thus, activation ratio may be the more pertinent molecular parameter in full mutation women in determining the degree of cognitive and physical phenotypic involvement.

AB - Females who are affected by fragile X syndrome (FXS) can have significant physical, neuropsychological and emotional involvement. This study was designed to explore the relationships between these three domains and to learn how the degree of involvement in each of these phenotypic areas relates to molecular parameters including CGG repeat length and activation ratio (the proportion of normal FMR1 alleles on the active X chromosome). Three groups of females were studied: 35 women who grew up in a fragile X family but do not carry an FMR1 mutation, 92 women with a premutation, and 29 women with a full mutation. Correlations between neurocognitive, physical and emotional traits were calculated for each of the three groups. Within the full mutation group significant correlations were seen between schizotypal traits and full scale IQ. The Lie scale was significantly correlated with the physical findings index. The activation ratio correlated significantly with the measure of executive function (r = .50, P = .01). There was a trend toward correlations of activation ratio with the physical index score, outer ear prominence and IQ. CGG repeat number significantly correlated only with the physical index (r = .44, P = .01). Thus, activation ratio may be the more pertinent molecular parameter in full mutation women in determining the degree of cognitive and physical phenotypic involvement.

KW - CGG repeats

KW - fragile X females

KW - neurocognitive deficits

KW - physical findings

KW - schizotypy

KW - X-inactivation ratio

UR - http://www.scopus.com/inward/record.url?scp=0029896683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029896683&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-8628(19960809)64:2<340::AID-AJMG21>3.0.CO;2-E

DO - 10.1002/(SICI)1096-8628(19960809)64:2<340::AID-AJMG21>3.0.CO;2-E

M3 - Article

C2 - 8844077

AN - SCOPUS:0029896683

VL - 64

SP - 340

EP - 345

JO - American Journal of Medical Genetics

JF - American Journal of Medical Genetics

SN - 1552-4825

IS - 2

ER -